New Rx, generics, OTC, and devices for pharmacists.
New Rx, generics, and OTC for pharmacists
Approximately 7.8% of adults and 10% of children in the U.S. are afflicted with hay fever symptoms. Pharmacists are able to offer a number of over-the-counter solutions to improve patients' quality of life.
FDA approved eslicarbazepine acetate on November 8, 2013 as an adjunctive treatment of partial-onset seizures in adults.
New Rx, new generics, and new OTC
Like oral medications, topical analgesics can offer patients well-controlled pain relief, but they do so without adverse systemic effects.
New Rx, formulations, indications, and generics
FDA has approved non-prescription esomeprazole 20mg (Nexium 24HR, Pfizer).
Bringing a new tool to the arsenal of medications to treat type 2 diabetes, FDA recently approved the only once-weekly injectable pen for adults with type 2 diabetes—exenatide extended-release for injectable suspension (AstraZeneca, Bydureon Pen).
New Rx, indications, generics, and OTC